Evidence map›Paper›PMID 24825422›Full record

ArticleFertility and sterility2014

Trophoblast retrieval and isolation from the cervix (TRIC) for noninvasive prenatal screening at 5 to 20 weeks of gestation.

Jay M Bolnick, Brian A Kilburn, Swati Bajpayee, Nitya Reddy, Roohi Jeelani, Barbara Crone, Neil Simmerman, Manivinder Singh, Michael P Diamond, D Randall Armant

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Fertility and sterility, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06523543 (Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06523543 recruitingnot on this mapstarted 2024, after this paper: background citation

Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells

TypeobservationalSponsorUniversity Hospital, MontpellierRan2024 to 2028Enrolled25ConditionsPregnant WomenArmsInclusion (Visit 1 - Week 7-16), Second semester of pregnancy (Visit 2 - Week 20-24), Third semester of pregnancy (Visit 3- Week 34)
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.Extracellular vesicles and circulating nucleic acids · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Isolation of HLA-GRSC advances · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jay M BolnickDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Brian A KilburnDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Swati BajpayeeDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Nitya ReddyDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Roohi JeelaniDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Barbara CroneDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Neil SimmermanDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Manivinder SinghDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan.
Michael P DiamondDepartment of Obstetrics and Gynecology, Georgia Regents University, Augusta, Georgia.
D Randall ArmantDepartment of Obstetrics and Gynecology, C. S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan; Anatomy and Cell Biology, C.S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. Electronic address: d.armant@wayne.edu.
Wayne State University · USAugusta University · USNational Institutes of Health · US

Funding

Genetic Analysis of Human First Trimester Trophoblast in Ongoing PregnanciesR21HD071408 · NICHD · WAYNE STATE UNIVERSITY · PI ARMANT, DAVID RANDALL, DIAMOND, MICHAEL PETER · 2012 to 2013
$406k
Intramural NIH HHSNICHD NIH HHS HD071408NICHD NIH HHS R21 HD071408
6 · The paper itself

Abstract

objectiveTo use trophoblast cells accumulating in the endocervical canal at the beginning of pregnancy for noninvasive prenatal testing.

designProspective, double-blinded test for fetal gender.

settingAcademic medical center. PATIENT(S): Fifty-six women with singleton pregnancies at gestational age 5-20 weeks. INTERVENTION(S): Isolation of fetal cells from resident maternal cells in endocervical specimens using anti-human leukocyte antigen G coupled to magnetic nanoparticles; cell phenotyping immunofluorescently with a panel of trophoblast subtype-specific proteins; DNA integrity assessment with terminal dUTP nick-end labeling (TUNEL); and polymerase chain reaction (PCR) and fluorescent in situ hybridization (FISH) to detect sex chromosomes in individual cells. MAIN OUTCOME MEASURE(S): Trophoblast phenotype, TUNEL index, and percentage male cells. RESULT(S): The women were given a routine Papanicolaou test; fetal genders were verified from medical records. Recovery after immunomagnetic isolation averaged 746±59 cells across gestational age, with 99% expressing chorionic gonadotropin, whereas the depleted cell fraction expressed none. The isolated cells had an extravillous trophoblast phenotype and intact nuclear DNA (>95%). Fetal gender was determined in 20 specimens without error by PCR. The FISH analysis of isolated cells from male specimens validated their fetal origin. CONCLUSION(S): Noninvasive prenatal testing is feasible beginning at a gestational age of 5 weeks.

Indexed as

Immunomagnetic SeparationSex Determination AnalysisAcademic Medical CentersBiomarkersCell LineageCells, CulturedCervix UteriChorionic Gonadotropin, beta Subunit, HumanChromosomes, Human, XChromosomes, Human, YDNA FragmentationDouble-Blind MethodFemaleGenetic TestingGenotypeGestational AgeBiomarkersChorionic Gonadotropin, beta Subunit, HumanEndocervical canalfetal genderprenatal testingsingle-cell analysistrophoblast

Identifiers

PMID24825422
PMCPMC10411519
OpenAlexW2120898211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.